SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-20-000028
Filing Date
2020-11-27
Accepted
2020-11-27 15:30:10
Documents
14
Period of Report
2020-11-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20201123.htm   iXBRL 8-K 37165
  Complete submission text file 0001358403-20-000028.txt   178547

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20201123.xsd EX-101.SCH 2423
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20201123_cal.xml EX-101.CAL 710
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20201123_def.xml EX-101.DEF 1643
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20201123_lab.xml EX-101.LAB 24030
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20201123_pre.xml EX-101.PRE 12661
7 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20201123_htm.xml XML 10722
Mailing Address 2710 REED ROAD SUITE 160 HOUSTON TX 77051
Business Address 2710 REED ROAD SUITE 160 HOUSTON TX 77051 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 201354968
SIC: 2834 Pharmaceutical Preparations